Related Experiment Video

Updated: Jun 18, 2025

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

19.5K

Harmonizing hope: navigating the osteoarthritis melody through the CCL2/CCR2 axis for innovative therapeutic avenues

Mitra Abbasifard1, Hossein Khorramdelazad2

  • 1Department of Internal Medicine, School of Medicine, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Frontiers in Immunology
|July 30, 2024
PubMed

Insights

The CCL2/CCR2 axis significantly impacts osteoarthritis (OA) by driving inflammation and cartilage breakdown. Targeting this pathway offers promising new therapeutic strategies for OA management.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Immunology

Background:

  • Osteoarthritis (OA) pathogenesis involves complex molecular signaling.
  • The CCL2/CCR2 axis plays a critical role in OA development.
  • This axis influences inflammation, cartilage degradation, and joint homeostasis.

Purpose of the Study:

  • To review the molecular mechanisms of the CCL2/CCR2 axis in OA.
  • To identify key players and pathways amplifying the catabolic cascade in OA.
  • To discuss therapeutic strategies targeting the CCL2/CCR2 axis for OA treatment.

Main Methods:

  • Comprehensive literature review of recent research on OA and the CCL2/CCR2 axis.
  • Analysis of molecular mechanisms underlying OA pathogenesis.
  • Identification of therapeutic targets within the CCL2/CCR2 pathway.

Main Results:

  • The CCL2/CCR2 axis promotes immune cell recruitment in OA joints.
  • CCL2/CCR2 signaling influences chondrocyte behavior, favoring degeneration.
  • Key molecular players and mechanisms amplifying the OA catabolic cascade were identified.

Conclusions:

  • The CCL2/CCR2 axis is a central mediator in osteoarthritis.
  • Targeting the CCL2/CCR2 axis presents a promising therapeutic avenue for OA.
  • Further research into these pathways could redefine future OA management.
Keywords:
CCL2CCR2autoimmune diseaseinflammationosteoarthritis

More Related Videos

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

3.8K
Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers09:02

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers

Published on: August 10, 2020

7.5K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
967